Compare ADT Inc (ADT) vs Enveric Biosciences Inc (ENVB) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
ADT Inc vs Enveric Biosciences Inc — how do they compare? ADT Inc trades at $7.46 (market cap $5.58B), while Enveric Biosciences Inc trades at $1.45 (market cap $6.20M). The key difference: ADT Inc is far larger — about 900× Enveric Biosciences Inc's market cap, and ADT Inc pays a 2.88% dividend while Enveric Biosciences Inc pays none. Which is the better fit depends on your goals.
| ADT | ENVB | |
|---|---|---|
Market Cap | $5.58B | $6.20M |
Sector | Industrials | Health |
52-Week High | $8.85 | $17.40 |
52-Week Low | $6.30 | $1.27 |
Enterprise Value | $13.27B | $1.30M |
Dividend Yield | 2.88% | — |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
ADT trades at $7.64, down 0.13% today, with a bullish technical signal from moving averages. The company reported Q2 2026 EPS of $0.23, beating estimates, and maintains strong profitability with an 11.86% net margin. Recent news highlights ADT's sponsorship of National Night Out 2026 and recognition as a top home security brand by Newsweek in May 2026.
Outlook is positive with consistent earnings beats and a 47% analyst buy rating, but risks include high debt levels and competitive pressures. The stock offers value with a P/E of 10.61 and dividend yield near 1.6%, supported by AI-driven growth initiatives.
ENVB trades at $1.55, down 0.64% with a bullish technical signal despite negative profitability. The company shows promising clinical progress with its lead candidate EB-003, supported by recent FDA guidance and positive preclinical data. While quarterly earnings consistently beat expectations, the company remains unprofitable with negative ROE and ROA. Analyst sentiment is positive with 75% buy ratings.
Investment outlook hinges on successful drug development milestones, with regulatory progress and intellectual property expansion providing catalysts. Key risks include clinical trial outcomes, cash burn from operations, and dependence on financing activities. The stock presents speculative growth potential for risk-tolerant investors focused on biotech innovation.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About ADT Inc
ADT Inc is a provider of monitored security, interactive home and business automation, and related monitoring services in the United States and Canada. ADT offers residential, commercial, and multi-site customers a comprehensive set of burglary, video, access control, fire and smoke alarm, and medical alert solutions. It provides interactive home and business automation solutions designed to control access, react to movement, and sense carbon monoxide, flooding, changes in temperature or other environmental conditions, as well as address personal emergencies, such as injuries and medical emergencies. In addition, it offers professional monitoring of third-party devices through ADT Canopy platform. The product brands of the company are ADT and ADT Pulse, and Protection One brand.
Read more on ADT →About Enveric Biosciences Inc
Enveric Biosciences is a biotechnology company focused on developing next-generation psychedelic-inspired therapies for mental health and neuropsychiatric disorders.
Read more on ENVB →
